Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.

The global Pandemic Influenza Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pandemic Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pandemic Influenza Vaccine.

Report Scope

The Pandemic Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pandemic Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pandemic Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pandemic Influenza Vaccine Market Report

Report Metric	Details
Report Name	Pandemic Influenza Vaccine Market
CAGR	5%
Segment by Type	Whole Virus Vaccines Split Virus Vaccines Subunit Vaccines
Segment by Application	For Children (6 months to 3 years) For Adults and Children over 3 years
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer, Johnson & Johnson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pandemic Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pandemic Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pandemic Influenza Vaccine Market report?

Ans: The main players in the Pandemic Influenza Vaccine Market are CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer, Johnson & Johnson

What are the Application segmentation covered in the Pandemic Influenza Vaccine Market report?

Ans: The Applications covered in the Pandemic Influenza Vaccine Market report are For Children (6 months to 3 years), For Adults and Children over 3 years

What are the Type segmentation covered in the Pandemic Influenza Vaccine Market report?

Ans: The Types covered in the Pandemic Influenza Vaccine Market report are Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines

1 Pandemic Influenza Vaccine Market Overview

1.1 Product Overview and Scope of Pandemic Influenza Vaccine

1.2 Pandemic Influenza Vaccine Segment by Type

1.2.1 Global Pandemic Influenza Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Whole Virus Vaccines

1.2.3 Split Virus Vaccines

1.2.4 Subunit Vaccines

1.3 Pandemic Influenza Vaccine Segment by Application

1.3.1 Global Pandemic Influenza Vaccine Market Value by Application: (2024-2030)

1.3.2 For Children (6 months to 3 years)

1.3.3 For Adults and Children over 3 years

1.4 Global Pandemic Influenza Vaccine Market Size Estimates and Forecasts

1.4.1 Global Pandemic Influenza Vaccine Revenue 2019-2030

1.4.2 Global Pandemic Influenza Vaccine Sales 2019-2030

1.4.3 Global Pandemic Influenza Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pandemic Influenza Vaccine Market Competition by Manufacturers

2.1 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pandemic Influenza Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Pandemic Influenza Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pandemic Influenza Vaccine, Product Type & Application

2.7 Pandemic Influenza Vaccine Market Competitive Situation and Trends

2.7.1 Pandemic Influenza Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Pandemic Influenza Vaccine Players Market Share by Revenue

2.7.3 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pandemic Influenza Vaccine Retrospective Market Scenario by Region

3.1 Global Pandemic Influenza Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pandemic Influenza Vaccine Global Pandemic Influenza Vaccine Sales by Region: 2019-2030

3.2.1 Global Pandemic Influenza Vaccine Sales by Region: 2019-2024

3.2.2 Global Pandemic Influenza Vaccine Sales by Region: 2025-2030

3.3 Global Pandemic Influenza Vaccine Global Pandemic Influenza Vaccine Revenue by Region: 2019-2030

3.3.1 Global Pandemic Influenza Vaccine Revenue by Region: 2019-2024

3.3.2 Global Pandemic Influenza Vaccine Revenue by Region: 2025-2030

3.4 North America Pandemic Influenza Vaccine Market Facts & Figures by Country

3.4.1 North America Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pandemic Influenza Vaccine Sales by Country (2019-2030)

3.4.3 North America Pandemic Influenza Vaccine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pandemic Influenza Vaccine Market Facts & Figures by Country

3.5.1 Europe Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pandemic Influenza Vaccine Sales by Country (2019-2030)

3.5.3 Europe Pandemic Influenza Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pandemic Influenza Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Pandemic Influenza Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pandemic Influenza Vaccine Market Facts & Figures by Country

3.7.1 Latin America Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pandemic Influenza Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Pandemic Influenza Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pandemic Influenza Vaccine Sales by Type (2019-2030)

4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2019-2024)

4.1.2 Global Pandemic Influenza Vaccine Sales by Type (2025-2030)

4.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Pandemic Influenza Vaccine Revenue by Type (2019-2030)

4.2.1 Global Pandemic Influenza Vaccine Revenue by Type (2019-2024)

4.2.2 Global Pandemic Influenza Vaccine Revenue by Type (2025-2030)

4.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Pandemic Influenza Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pandemic Influenza Vaccine Sales by Application (2019-2030)

5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2019-2024)

5.1.2 Global Pandemic Influenza Vaccine Sales by Application (2025-2030)

5.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Pandemic Influenza Vaccine Revenue by Application (2019-2030)

5.2.1 Global Pandemic Influenza Vaccine Revenue by Application (2019-2024)

5.2.2 Global Pandemic Influenza Vaccine Revenue by Application (2025-2030)

5.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Pandemic Influenza Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 CSL

6.1.1 CSL Corporation Information

6.1.2 CSL Description and Business Overview

6.1.3 CSL Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 CSL Pandemic Influenza Vaccine Product Portfolio

6.1.5 CSL Recent Developments/Updates

6.2 GSK

6.2.1 GSK Corporation Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK Pandemic Influenza Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Sanofi Pasteur

6.3.1 Sanofi Pasteur Corporation Information

6.3.2 Sanofi Pasteur Description and Business Overview

6.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Pasteur Pandemic Influenza Vaccine Product Portfolio

6.3.5 Sanofi Pasteur Recent Developments/Updates

6.4 Mylan

6.4.1 Mylan Corporation Information

6.4.2 Mylan Description and Business Overview

6.4.3 Mylan Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Mylan Pandemic Influenza Vaccine Product Portfolio

6.4.5 Mylan Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Corporation Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AstraZeneca Pandemic Influenza Vaccine Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Pfizer Pandemic Influenza Vaccine Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Johnson & Johnson

6.6.1 Johnson & Johnson Corporation Information

6.6.2 Johnson & Johnson Description and Business Overview

6.6.3 Johnson & Johnson Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Johnson & Johnson Pandemic Influenza Vaccine Product Portfolio

6.7.5 Johnson & Johnson Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pandemic Influenza Vaccine Industry Chain Analysis

7.2 Pandemic Influenza Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pandemic Influenza Vaccine Production Mode & Process

7.4 Pandemic Influenza Vaccine Sales and Marketing

7.4.1 Pandemic Influenza Vaccine Sales Channels

7.4.2 Pandemic Influenza Vaccine Distributors

7.5 Pandemic Influenza Vaccine Customers

8 Pandemic Influenza Vaccine Market Dynamics

8.1 Pandemic Influenza Vaccine Industry Trends

8.2 Pandemic Influenza Vaccine Market Drivers

8.3 Pandemic Influenza Vaccine Market Challenges

8.4 Pandemic Influenza Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Pandemic Influenza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pandemic Influenza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Pandemic Influenza Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pandemic Influenza Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pandemic Influenza Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pandemic Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pandemic Influenza Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pandemic Influenza Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pandemic Influenza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pandemic Influenza Vaccine Sales by Region (2019-2024) & (K Doses)

Table 18. Global Pandemic Influenza Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Pandemic Influenza Vaccine Sales by Region (2025-2030) & (K Doses)

Table 20. Global Pandemic Influenza Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Pandemic Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Pandemic Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Pandemic Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pandemic Influenza Vaccine Sales by Country (2019-2024) & (K Doses)

Table 27. North America Pandemic Influenza Vaccine Sales by Country (2025-2030) & (K Doses)

Table 28. North America Pandemic Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pandemic Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pandemic Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pandemic Influenza Vaccine Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Pandemic Influenza Vaccine Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Pandemic Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pandemic Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pandemic Influenza Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pandemic Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pandemic Influenza Vaccine Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Pandemic Influenza Vaccine Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Pandemic Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pandemic Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Pandemic Influenza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Pandemic Influenza Vaccine Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Pandemic Influenza Vaccine Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Pandemic Influenza Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Pandemic Influenza Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pandemic Influenza Vaccine Sales (K Doses) by Type (2019-2024)

Table 51. Global Pandemic Influenza Vaccine Sales (K Doses) by Type (2025-2030)

Table 52. Global Pandemic Influenza Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Pandemic Influenza Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Pandemic Influenza Vaccine Price (USD/Dose) by Type (2019-2024)

Table 59. Global Pandemic Influenza Vaccine Price (USD/Dose) by Type (2025-2030)

Table 60. Global Pandemic Influenza Vaccine Sales (K Doses) by Application (2019-2024)

Table 61. Global Pandemic Influenza Vaccine Sales (K Doses) by Application (2025-2030)

Table 62. Global Pandemic Influenza Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Pandemic Influenza Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Pandemic Influenza Vaccine Price (USD/Dose) by Application (2019-2024)

Table 69. Global Pandemic Influenza Vaccine Price (USD/Dose) by Application (2025-2030)

Table 70. CSL Corporation Information

Table 71. CSL Description and Business Overview

Table 72. CSL Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. CSL Pandemic Influenza Vaccine Product

Table 74. CSL Recent Developments/Updates

Table 75. GSK Corporation Information

Table 76. GSK Description and Business Overview

Table 77. GSK Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. GSK Pandemic Influenza Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Sanofi Pasteur Corporation Information

Table 81. Sanofi Pasteur Description and Business Overview

Table 82. Sanofi Pasteur Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. Sanofi Pasteur Pandemic Influenza Vaccine Product

Table 84. Sanofi Pasteur Recent Developments/Updates

Table 85. Mylan Corporation Information

Table 86. Mylan Description and Business Overview

Table 87. Mylan Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. Mylan Pandemic Influenza Vaccine Product

Table 89. Mylan Recent Developments/Updates

Table 90. AstraZeneca Corporation Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. AstraZeneca Pandemic Influenza Vaccine Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Pfizer Corporation Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. Pfizer Pandemic Influenza Vaccine Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Johnson & Johnson Corporation Information

Table 101. Johnson & Johnson Description and Business Overview

Table 102. Johnson & Johnson Pandemic Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. Johnson & Johnson Pandemic Influenza Vaccine Product

Table 104. Johnson & Johnson Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Pandemic Influenza Vaccine Distributors List

Table 108. Pandemic Influenza Vaccine Customers List

Table 109. Pandemic Influenza Vaccine Market Trends

Table 110. Pandemic Influenza Vaccine Market Drivers

Table 111. Pandemic Influenza Vaccine Market Challenges

Table 112. Pandemic Influenza Vaccine Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Pandemic Influenza Vaccine

Figure 2. Global Pandemic Influenza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pandemic Influenza Vaccine Market Share by Type in 2023 & 2030

Figure 4. Whole Virus Vaccines Product Picture

Figure 5. Split Virus Vaccines Product Picture

Figure 6. Subunit Vaccines Product Picture

Figure 7. Global Pandemic Influenza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Pandemic Influenza Vaccine Market Share by Application in 2023 & 2030

Figure 9. For Children (6 months to 3 years)

Figure 10. For Adults and Children over 3 years

Figure 11. Global Pandemic Influenza Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Pandemic Influenza Vaccine Market Size (2019-2030) & (US$ Million)

Figure 13. Global Pandemic Influenza Vaccine Sales (2019-2030) & (K Doses)

Figure 14. Global Pandemic Influenza Vaccine Average Price (USD/Dose) & (2019-2030)

Figure 15. Pandemic Influenza Vaccine Report Years Considered

Figure 16. Pandemic Influenza Vaccine Sales Share by Manufacturers in 2023

Figure 17. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Pandemic Influenza Vaccine Players: Market Share by Revenue in 2023

Figure 19. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Pandemic Influenza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Pandemic Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 22. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 26. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 27. Germany Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2019-2030)

Figure 34. China Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Pandemic Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 45. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Pandemic Influenza Vaccine Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. U.A.E Pandemic Influenza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Pandemic Influenza Vaccine by Type (2019-2030)

Figure 55. Global Revenue Market Share of Pandemic Influenza Vaccine by Type (2019-2030)

Figure 56. Global Pandemic Influenza Vaccine Price (USD/Dose) by Type (2019-2030)

Figure 57. Global Sales Market Share of Pandemic Influenza Vaccine by Application (2019-2030)

Figure 58. Global Revenue Market Share of Pandemic Influenza Vaccine by Application (2019-2030)

Figure 59. Global Pandemic Influenza Vaccine Price (USD/Dose) by Application (2019-2030)

Figure 60. Pandemic Influenza Vaccine Value Chain

Figure 61. Pandemic Influenza Vaccine Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions